Budget impact analysis of cervical cancer screening in Portugal: comparison of cytology and primary HPV screening strategies

Table 7 Clinical performance of triaging hrHPV+ women with HPV16/18 genotyping and using LBC to triage OHR

Study	Sensitivity (CIN2+)	Specificity (CIN2+)	Relative cost of Comparator 2
ATHENA (Wright T et al., 2014 [27])	93.3%	62.8%	− 24%
ATHENA (Castle PE et al., 2011 [28])	51.8%	75.3%	− 24%
POBASCAM (Dijkstra M et al., 2013 [32])	90.3%	57.6%	−25%
PavDag (Stanczuk GA. et al., 2017 [33])	93.3%	52.7%	−24%

ISSN: 1471-2458